Based upon the evidence, leflunomide and consequently teriflunomide are candidates for personalized dosing for use in RA. The small unbound fraction of teriflunomide within the blood makes ...

Three randomized groups of 190 healthy subjects received single intravenous dose (4 mg/kg) of either LusiNEX or originator products (EU-RoActemra or US-Actemra). After dosing, study participants ...

Roche's rheumatoid arthritis (RA) drug Actemra/RoActemra could be an important therapy for the life-threatening autoimmune disease systemic sclerosis (SSc), according to the US FDA. The US ...

Among patients with heavily pretreated chronic lymphocytic leukemia, treatment with Epkinly monotherapy showed deep responses ...